Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
  • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
  • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
  • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
  • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
  • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
  • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/04—Antibacterial agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
  • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
  • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
  • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
  • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
  • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
  • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Communicable Diseases (AREA)
• Pharmacology & Pharmacy (AREA)
• Oncology (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Cephalosporin Compounds (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (1)

Publications (2)

Family

ID=10531380

Family Applications (2)

Family Applications Before (1)

Country Status (19)

Families Citing this family (1)

Family Cites Families (3)

• 1983
  • 1983-06-29 SE SE8303728A patent/SE8303728D0/xx not_active Application Discontinuation
  • 1983-06-29 LU LU84886A patent/LU84886A1/fr unknown
  • 1983-06-29 PT PT76959A patent/PT76959B/pt unknown
  • 1983-06-29 ES ES523681A patent/ES8500956A1/es not_active Expired
  • 1983-06-29 ZA ZA834757A patent/ZA834757B/xx unknown
  • 1983-06-29 PL PL24274783A patent/PL242747A1/xx unknown
  • 1983-06-29 AU AU16380/83A patent/AU1638083A/en not_active Abandoned
  • 1983-06-29 BE BE0/211080A patent/BE897162A/fr not_active IP Right Cessation
  • 1983-06-29 FI FI832384A patent/FI832384A7/fi not_active Application Discontinuation
  • 1983-06-29 KR KR1019830002946A patent/KR840005150A/ko not_active Withdrawn
  • 1983-06-29 JP JP58116232A patent/JPS5913787A/ja active Pending
  • 1983-06-29 ZA ZA834759A patent/ZA834759B/xx unknown
  • 1983-06-29 KR KR1019830002945A patent/KR840005151A/ko not_active Withdrawn
  • 1983-06-29 JP JP58116230A patent/JPS5913788A/ja active Pending
  • 1983-06-29 BE BE0/211081A patent/BE897163A/fr not_active IP Right Cessation
  • 1983-06-29 NL NL8302308A patent/NL8302308A/nl not_active Application Discontinuation
  • 1983-06-29 GB GB08317618A patent/GB2123415A/en not_active Withdrawn
  • 1983-06-29 DE DE19833323450 patent/DE3323450A1/de not_active Withdrawn
  • 1983-06-29 GR GR71808A patent/GR77528B/el unknown
  • 1983-06-29 DK DK298983A patent/DK298983A/da not_active Application Discontinuation
  • 1983-06-29 PL PL24979583A patent/PL249795A1/xx unknown
  • 1983-06-29 ZA ZA834758A patent/ZA834758B/xx unknown
  • 1983-06-29 FR FR8310794A patent/FR2529556A1/fr active Pending
  • 1983-06-29 IT IT48599/83A patent/IT1173727B/it active
  • 1983-06-29 JP JP58116231A patent/JPS5913786A/ja active Pending
  • 1983-06-29 NO NO832375A patent/NO832375L/no unknown
  • 1983-12-22 FR FR8320605A patent/FR2543949A1/fr active Pending
• 1984
  • 1984-02-27 ES ES530071A patent/ES530071A0/es active Granted

Also Published As

Similar Documents